Bio-Techne Corporation, in collaboration with Wilson Wolf Manufacturing and CellReady, has announced that the Gates Institute's Translational Sciences Laboratory has been awarded a $300,000 G-Rex® Grant. This grant will be used to develop a modular G-Rex centric CAR T-cell manufacturing platform at the University of Colorado Anschutz Medical Campus. The funding aims to optimize cell and gene therapy manufacturing processes, aligning with the Gates Institute's goals to enhance efficiency and adaptability. This initiative highlights the collective efforts of multiple organizations, including Bio-Techne, to advance cell and gene therapy technologies.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。